use of phosphoglyzeriden containing phosphoglycero ether for the treatment of neurodegenerative diseases in the severely disabled children

摘要

PCT No. PCT/FR96/01028 Sec. 371 Date Mar. 4, 1997 Sec. 102(e) Date Mar. 4, 1997 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/02828 PCT Pub. Date Jan. 30, 1997The present invention is directed to plasmalogens and pharmaceutical compositions thereof which are useful for treating neurodegenerative diseases. Carbons 1 and 2 of the phosphoglyceryl backbone of the plasmaolgens have from 10-24 carbon atoms containing from 1 to 6 double bonds. The phosphoryl group is bonded to choline, ethanolamine, serine or inositol.